Newsroom

Share:

EmailFacebookLinkedInXWhatsAppShare
Publication date (field_publication_date)
Science Highlights · December 19, 2022

NIBIB-funded researchers are developing a new method to treat pancreatic cancer. In their study, they combined an injectable radioactive gel with systemic chemotherapy in multiple mouse models of the disease. The treatment resulted in tumor regression in all evaluated models, an unprecedented result for this genetically diverse and aggressive type of cancer.

NIBIB in the News · December 8, 2022

Researchers led a large-scale global machine learning effort to securely aggregate knowledge from brain scans of 6,314 glioblastoma (GBM) patients at 71 sites around the globe and develop a model that can enhance identification and prediction of boundaries in three tumor sub-compartments, without compromising patient privacy. Source: University of Pennsylvania School of Medicine/Science Daily

NIBIB in the News · December 8, 2022

Biomedical and genetic engineers have designed a small fluorescent protein that emits and absorbs light that penetrates deep into biological tissue. Tailored to wavelengths in the near-infrared (NIR) spectrum, this protein can help researchers capture deeper, cleaner, more precise biomedical images. Source: Duke University/Science Daily

NIBIB in the News · December 5, 2022

Researchers can detect 'toxic' small aggregates of a particular protein in the blood of individuals with Alzheimer's disease, as well as in individuals who showed no signs of cognitive impairment at the time the blood sample was taken, but who developed it at a later date. This blood test picks up oligomers -- or small, misfolded aggregates -- of the amyloid beta protein, which scientists believe triggers the development of Alzheimer's. Source: University of Washington/Science Daily

NIBIB in the News · December 5, 2022

Researchers have applied emerging electronic tattoo (e-tattoo) technology to the tricky task of measuring stress levels by attaching a device to people's palms. Source: University of Texas at Austin/Science Daily

Science Highlights · November 28, 2022

NIBIB-funded researchers are fine-tuning a wearable, cuffless blood pressure monitor. Made of graphene, one of the thinnest materials in the world, the device is worn on the underside of the wrist and can measure blood pressure with comparable accuracy to a standard blood pressure cuff.

Press Releases · November 22, 2022

Reporting a positive or negative test result just became easier through a new website from the National Institutes of Health. MakeMyTestCount.org, developed through NIH’s Rapid Acceleration of Diagnostics (RADx®) Tech program, allows users to anonymously report the results of any brand of at-home COVID-19 test.

NIBIB in the News · November 21, 2022

Researchers have developed an innovative way to 'see' the fine structure and chemical composition of human cells with unmatched clarity and precision. Their technique takes a creative approach to signal detection. Source: Beckman Institute for Advanced Science and Technology/Science Daily

Science Highlights · November 18, 2022

The National Institutes of Health has awarded research funding for seven pilot projects developing early stage, yet groundbreaking neuro-technologies. The innovative projects would enable new medical devices to diagnose and treat both acute and chronic disorders, from neuropathic pain to mental illness.